Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records

Stroke

Volumn 45, Issue 7, 2014, Pages 2066-2071

  Dregan, Alex ^a,b   Van Staa, Tjeerd P ^c,d   McDermott, Lisa ^a,e   McCann, Gerard ^c   Ashworth, Mark ^a   Charlton, Judith ^a   Wolfe, Charles D A ^a,b   Rudd, Anthony ^a,b   Yardley, Lucy ^e   Gulliford, Martin C ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

blood pressure; cholesterol; electronic health records; intervention studies; secondary prevention; stroke

Indexed keywords

ANTITHROMBOCYTIC AGENT; CHOLESTEROL;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR ACCIDENT; CONSULTATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTRONIC MEDICAL RECORD; FEMALE; GENERAL PRACTICE; HEALTH CARE COST; HOSPITAL INFORMATION SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SECONDARY PREVENTION; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; CHOLESTEROL; ELECTRONIC HEALTH RECORDS; INTERVENTION STUDIES; SECONDARY PREVENTION; STROKE;

AGED; AGED, 80 AND OVER; ELECTRONIC HEALTH RECORDS; FAMILY PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 84903784168     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005713     Document Type: Article

References (26)

1. Mohan KM, Wolfe CD, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: A systematic review and meta-analysis. Stroke. 2011;42: 1489-1494.
2. Intercollegiate Stroke Working Party. National Clinical Guidelines for Stroke. 4th ed. London, United Kingdom: Royal College of Physicians of London; 2012. http://www.rcplondon.ac.uk/sites/default/files/nationalclinical- guidelines-for-stroke-fourth-edition.pdf. Accessed January 20, 2014.
3. Rudd AG, Lowe D, Hoffman A, Irwin P, Pearson M. Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of Stroke. Age Ageing. 2004;33: 280-286. (Pubitemid 38635046)
4. Pronovost PJ. Enhancing physicians' use of clinical guidelines. JAMA. 2013;310: 2501-2502.
5. Staa TP, Goldacre B, Gulliford M, Cassell J, Pirmohamed M, Taweel A, et al. Pragmatic randomised trials using routine electronic health records: putting them to the test. BMJ. 2012;344:e55.
6. Dregan A, van Staa T, McDermott L, McCann G, Ashworth M, Charlton J, et al; eCRT Research Team. Cluster randomized trial in the general practice research database: 2. Secondary prevention after first stroke (eCRT study): study protocol for a randomized controlled trial. Trials. 2012;13:181.
7. Clinical Practice Research Datalink. http://www.cprd.com/intro.asp. Accessed January 20, 2014.
8. Williams T, van Staa TP, Puri S, Eaton S. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf. 2012;3: 89-99.
9. Altman DG, Bland JM. Treatment allocation by minimisation. BMJ. 2005;330:843.
10. Dregan A, Toschke MA, Wolfe CD, Rudd A, Ashworth M, Gulliford MC; eCRT Research Team. Utility of electronic patient records in primary care for stroke secondary prevention trials. BMC Public Health. 2011;11:86.
11. Toschke AM, Wolfe C, Heuschmann P, Rudd A, Gulliford M. The effect of antihypertensive treatment after stroke. An analysis of the General Practice Research Database (GPRD). Cerebrovasc Dis. 2009;28: 105-111.
12. McDermott L, Yardley L, Little P, Ashworth M, Gulliford M; eCRT Research Team. Developing a computer delivered, theory based intervention for guideline implementation in general practice. BMC Fam Pract. 2010;11:90.
13. PROGRESS Collaborative Group. Randomised trial of a perindopril- based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358: 1033-1041.
14. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
15. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355: 549-559. (Pubitemid 44202151)
16. Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A III, et al SPARCL Investigators. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2007;38: 3198-3204. (Pubitemid 350175737)
17. Gulliford MC, Charlton J, Ashworth M, Rudd AG, Toschke AM; eCRT Research Team. Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database. PLoS One. 2009;4:e7168.
18. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324: 71-86.
19. National Institute for Health and Clinical Excellence. Clopidogrel and Modified-Release Dipyridamole for the Prevention of Occlusive Vascular Events. London, United Kingdom: National Institute for Health and Clinical Excellence. http://www.nice.org.uk/nicemedia/ live/13285/52030/52030.pdf. Accessed January 20, 2014.
20. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 2006;35: 1292-1300. (Pubitemid 44605554)
21. Teerenstra S, Eldridge S, Graff M, de Hoop E, Borm GF. A simple sample size formula for analysis of covariance in cluster randomized trials. Stat Med. 2012;31: 2169-2178.
22. Ukoumunne OC, Carlin JB, Gulliford MC. A simulation study of odds ratio estimation for binary outcomes from cluster randomized trials. Stat Med. 2007;26: 3415-3428. (Pubitemid 47162000)
23. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): A tool to help trial designers. J Clin Epidemiol. 2009;62: 464-475.
24. Wolfe CD, Redfern J, Rudd AG, Grieve AP, Heuschmann PU, McKevitt C. Cluster randomized controlled trial of a patient and general practitioner intervention to improve the management of multiple risk factors after stroke: stop stroke. Stroke. 2010;41: 2470-2476.
25. Johnston SC, Sidney S, Hills NK, Grosvenor D, Klingman JG, Bernstein A, et al. Standardized discharge orders after stroke: results of the quality improvement in stroke prevention (QUISP) cluster randomized trial. Ann Neurol. 2010;67: 579-589.
26. Roshanov PS, Fernandes N, Wilczynski JM, Hemens BJ, You JJ, Handler SM, et al. Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ. 2013; 346:f657.